Luís Masmiquel

4.3k citations
15 papers · 589 indexed · 1 hit paper · h-index 9
Topics
Diabetes Treatment and Management (6 papers)Pharmacology and Obesity Treatment (3 papers)Phytase and its Applications (3 papers)

In The Last Decade

Luís Masmiquel

14 papers receiving 582 citations

Hit Papers

Efficacy and safety of once-weekly semaglutide versus onc...20172026202020232017100200300

Peers

Luís Masmiquel
Comparison fields: 5 of 75
  • Endocrinology, Diabetes and Metabolism 421
  • Molecular Biology 296
  • Surgery 109
  • Pharmacology 97
  • Plant Science 56
Replace Julio Rosenstock with:
Julio Rosenstock United States
Hideyuki Kabasawa Japan
Saleem Ullah Shahid Pakistan
Grazia Michetti Italy
Anandharajan Rathinasabapathy United States
Zelija Velija-Ašimi Bosnia and Herzegovina
Andreas Melidonis Greece
Xiaofei Su China
Hua Jiang China
M Nesović Serbia
Luís Masmiquel relative to Julio Rosenstock United States Julio Rosenstock's profile →
Citations per field
00.5×10×15×18.7×
Julio Rosenstock · 1×
Citations per year

Countries citing papers authored by Luís Masmiquel

Since Specialization
Citations

This map shows the geographic impact of Luís Masmiquel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Masmiquel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Masmiquel more than expected).

Fields of papers citing papers by Luís Masmiquel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Masmiquel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Masmiquel. The network helps show where Luís Masmiquel may publish in the future.

Co-authorship network of co-authors of Luís Masmiquel

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Masmiquel. A scholar is included among the top collaborators of Luís Masmiquel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Masmiquel. Luís Masmiquel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 19
2 42
3 2
4 5
5 10
6 50
7
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trialbreakdown →
368
8 8
9 3
10 15
11 42
12 12
13 1
14 2
15 10

About Luís Masmiquel

Luís Masmiquel is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Rheumatology, having authored 15 papers that have together received 589 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Pharmacology and Obesity Treatment (3 papers) and Phytase and its Applications (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (421 citations), Pharmacology (97 citations) and Molecular Biology (296 citations). Luís Masmiquel has collaborated with scholars based in Spain, Denmark and United Kingdom. Frequent co-authors include Julie Derving Karsbøl, Harish Kumar, Francis Chun Chung Chow, Mehmet Sargın, Bo Åhrén, Pilar Sanchís, F. Gráses, Regina Fortuny, Antonia Costa‐Bauzá and Miquel Adrover. Their work appears in journals such as Scientific Reports, The American Journal of Medicine and Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026